ProCE Banner Events

Optimizing TKI Therapy in CML: Practical Approaches to Improve Patient Outcomes

This presentation provides a comprehensive overview of the role of TKIs in managing CML, with a focus on both early and later-line therapies. The session will cover key efficacy and safety data associated with TKI use to guide optimal therapy selection. Additionally, the presentation will explore effective strategies on managing adverse events to enhance patient adherence and improve clinical outcomes.

Learning Objectives

  • Review guideline recommendations for TKI therapy for CML
  • Summarize evidence for long-term efficacy and safety of TKI therapy in CML
  • Highlight effective patient management strategies to manage adverse events, optimize adherence, and improve clinical outcomes with TKI therapies
Time and location

Thursday, December 12, 2024

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Faculty
Jerald Radich, MD

Professor
Translational Science and Therapeutics Division
Kurt Enslein Endowed Chair
Fred Hutch Cancer Center
Seattle, WA